Reviewing Alternate Health (OTCMKTS:AHGIF) and Omnicell (NASDAQ:OMCL)

Alternate Health (OTCMKTS:AHGIF) and Omnicell (NASDAQ:OMCL) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership and earnings.

Profitability

This table compares Alternate Health and Omnicell’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alternate Health	N/A	N/A	N/A
Omnicell	2.01%	4.27%	2.44%

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Alternate Health and Omnicell, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alternate Health	0	0	0	0	0.00
Omnicell	1	3	4	0	2.38

Omnicell has a consensus target price of $46.71, indicating a potential upside of 50.93%. Given Omnicell’s stronger consensus rating and higher possible upside, analysts clearly believe Omnicell is more favorable than Alternate Health.

Institutional and Insider Ownership

97.7% of Omnicell shares are held by institutional investors. 2.5% of Omnicell shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Alternate Health and Omnicell”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alternate Health	N/A	N/A	N/A	N/A	N/A
Omnicell	$1.11 billion	1.28	$12.53 million	$0.50	61.90

Omnicell has higher revenue and earnings than Alternate Health.

Summary

Omnicell beats Alternate Health on 9 of the 9 factors compared between the two stocks.

About Alternate Health

Alternate Health Corp., a diversified healthcare company, provides cloud based software solutions in Canada. It offers medical practice and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry. The company is headquartered in Toronto, Canada.

About Omnicell

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.